Human medicines European public assessment report (EPAR): Dimethyl fumarate Neuraxpharm, dimethyl fumarate, Status: Opinion
Human medicines European public assessment report (EPAR): Dimethyl fumarate Neuraxpharm, dimethyl fumarate, Status: Opinion
Human medicines European public assessment report (EPAR): Dimethyl fumarate Neuraxpharm, dimethyl fumarate, Status: Opinion
Summary of opinion: Retsevmo Positive
Product Management Services (PMS) deep-dive webinar, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 February 2024, 10:00 (CET) to 22 February 2024, 12:00 (CET)
Technical Webinar: Regulatory Procedure Management for PLM in IRIS for Network Users, Online, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2024, 14:00 (CET) to 27 February 2024, 16:00 (CET)
Agenda of the 123rd meeting of the Management Board : 21 March 2024
Paxlovid
Template for pharmacovigilance assessment information sharing
Eleventh industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, 4 December 2023
Guidance on the electronic submission of information on investigational medicinal products for human use in the Extended EudraVigilance medicinal product dictionary (XEVMPD)
Article 57 product data